Printer Friendly

JOHNSON & JOHNSON ABSORBABLE PIN IS LATEST TREATMENT FOR BUNIONS

 JOHNSON & JOHNSON ABSORBABLE PIN IS LATEST TREATMENT FOR BUNIONS
 RAYNHAM, Mass., Oct. 21 /PRNewswire/ -- Four out of five adults will suffer foot problems at one point in their lives. But since a majority of these problems require elective surgery to correct them, many people will delay an operation and live with the pain. Now, Johnson & Johnson Orthopaedics has developed a product that makes foot surgery easier.
 The latest technology is an absorbable pin called OrthoSorb(R), developed for foot, hand and knee surgery. The absorbable pin secures fractured or surgically cut bones until they heal, much like the traditional stainless steel K-wire. What makes the absorbable pin revolutionary is after the bones heal, the pin completely absorbs into the body within approximately six months.
 One surgery where the OrthoSorb Absorbable Pin is gaining increasing popularity is the bunionectomy. Bunionectomies are performed to remove bunions, enlargements or bumps on the inside of the big toe joint that cause the large toe to turn inward and crowd other toes. A common foot ailment, bunions are an inherited deformity that affect both men and women.
 Traditionally, during a bunionectomy a small portion of bone from the big toe is removed and the toe is realigned to a more normal and corrected position. To stabilize the healing bones, surgical pins, wires or screws are inserted into the toe. Until the introduction of OrthoSorb Absorbable Pin, a second procedure was required to remove the surgical hardware after the toe healed.
 Due to OrthoSorb's unique ability to absorb into the body, the need of a second procedure has been eliminated. Other benefits to the patient include a shorter recovery time, better aesthetic appearance because the pin is enclosed in the foot, virtually no risk of post- operative infection and quicker return to everyday activities and the workplace.
 Conversely, when a bunionectomy is performed with a K-wire stainless steel pin, patients are typically off their feet for weeks. They must be very careful cleaning the area where K-wire protrudes from the skin, must take precautions when showering and remain out of work for two to three weeks.
 Dr. David C. Novicki, DPM, secretary/treasurer of the American College of Foot Surgeons comments, "Within the next two decades, I believe steel pins will be medical history. Already the buzz word in the orthopedic profession is 'absorbable.'"
 OrthoSorb is the only absorbable pin on the market today made of the synthetic absorbable material known as poly-p-dioxanone. This synthetic material slowly absorbs into the body once the healing is complete through a process called hydrolysis. Through hydrolysis, water in the body breaks down the pin material and the by-products are removed normally. The OrthoSorb absorbable pin has been cleared by the FDA.
 Johnson & Johnson Orthopaedics Inc. is a member of the Johnson & Johnson family of companies. It manufactures and markets products for the repair of the musculoskeletal system, including joint prostheses, casting materials, and absorbable fixation devices.
 -0- 10/21/92
 /CONTACT: Jane Aries of Burnieika Group, 617-451-9225, for Johnson & Johnson/ CO: Johnson & Johnson ST: Massachusetts IN: HEA SU:


CH -- NEFNS1 -- 2632 10/21/92 07:31 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 1992
Words:518
Previous Article:BAROID ANNOUNCES 1992 THIRD QUARTER RESULTS
Next Article:THE PAN PACIFIC HOTEL SAN FRANCISCO WELCOMES HOLIDAY SHOPPERS
Topics:


Related Articles
VHA SIGNS $1.2 BILLION SOLE-SOURCE AGREEMENTS FOR SUTURES, STAPLERS AND ENDOSCOPIC SURGERY PRODUCTS WITH JOHNSON & JOHNSON SUBSIDIARIES
Focal, Inc. Grants Surgical Sealant Product Rights To Ethicon, Inc., a Johnson & Johnson Company
Focal, Inc. Introduces FocalSeal Surgical Sealant in Minimally Invasive Lung Volume Reduction Surgery for Emphysema
CLOSURE Medical Corporation Receives European Marketing Approval
CLOSURE Medical Corporation Receives ISO-9001 Registration
Focal, Inc. Completes Enrollment in Pivotal U.S. Clinical Trial of FocalSeal-L Surgical Sealant
Ethicon Endo-Surgery, Inc. Announces Innovative Device That Eliminates Videoscopic Surgical Knot Tying
Focal, Inc. Completes European Neurosurgery Clinical Trial Enrollment Using FocalSeal-S Surgical Sealant.
Integra LifeSciences Announces Acquisition of NeuroCare, A Leader in Neurosurgical Implants and Monitoring Devices.
Focal Inc. Announces Third Quarter Results Conference Call.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters